News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Prevention
Initiative to help cancer patients quit smoking
Smoking rates in the United States have decreased dramatically in recent decades, but many smokers diagnosed with cancer continue to light up. To make smoking cessation a major focus at cancer centers, including Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, the National Cancer Institute (NCI) of the National Institutes […]
Research
Study prompts new ideas on cancers’ origins
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer — a finding that could upend the way scientists think about the origins of the disease. Researchers at Washington University School of Medicine in St. Louis have […]
In the Media, Research, Staff/Faculty Update
Undaunted explorer
Timothy Ley, MD, the Lewis T. and Rosalind B. Apple Professor of Medicine, has been investigating leukemia, particularly acute myeloid leukemia (AML), for decades. A glimpse of his research over just the past 10 to 15 years — featured in journals like Nature, Cell, the New England Journal of Medicine and Journal of the American Medical Association — illustrates how challenging […]
In the Media, Staff/Faculty Update
Medical School faculty named to National Academy of Inventors
Noted innovators Samuel Achilefu, PhD, David Holtzman, MD, and Eric Leuthardt, MD – faculty members at Washington University School of Medicine in St. Louis – have been named fellows of the National Academy of Inventors (NAI). The 2017 class of NAI fellows was announced Tuesday. They are recognized as fellows for demonstrating innovation in creating and facilitating […]
Research
How cells detect, mend DNA damage may improve chemotherapy
The busy world inside a cell is directed by its DNA blueprint. When the blueprints are altered, cells can sicken, die or become cancerous. To keep DNA in working order, cells have ways to detect and mend damaged DNA. Now, researchers at Washington University School of Medicine in St. Louis report that they have found […]
Research, Staff/Faculty Update
$6 million supports leukemia research
John F. DiPersio, MD, PhD, of Washington University School of Medicine in St. Louis, has received a $6 million outstanding investigator award from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to support research aimed at improving therapies for leukemia. DiPersio, the Virginia E. and Sam J. Golman Professor of Medicine […]
Staff/Faculty Update
Maher recognized by Lung Cancer Research Foundation
Christopher A. Maher, PhD, an assistant professor of medicine at Washington University School of Medicine and a Siteman Cancer Center research member, has received the William C. Rippe Award for Distinguished Research in Lung Cancer. Given by the Lung Cancer Research Foundation, the annual award goes to an “investigator whose proposal not only demonstrates exceptional […]
Clinical, In the Media
New gene-altering treatment offered for blood cancers
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved by the Food and Drug Administration (FDA) for types of advanced non-Hodgkin lymphoma in adults, the CAR-T cell therapy harnesses a patient’s […]
Research
Chemo-loaded nanoparticles target breast cancer that has spread to bone
Breast cancer that spreads often infiltrates bone, causing fractures and intense pain. In such cases, chemotherapy is ineffective because the environment of the bone protects the tumor, even as the drug has toxic side effects elsewhere in the body. Now, scientists at Washington University School of Medicine in St. Louis have developed a nanoparticle that […]
Staff/Faculty Update
Schreiber awarded Balzan Prize for pioneering cancer research
Robert D. Schreiber, PhD, the Andrew M. and Jane M. Bursky Distinguished Professor at Washington University School of Medicine, has been named a co-recipient of the Balzan Prize for his groundbreaking work in immunology and melanoma research. The award is meant to “foster culture, the sciences and the most meritorious initiatives in the cause of humanity, peace and fraternity among […]